In 2006, the worldwide prevalence of Alzheimer’s Disease (AD) was over 26 million. By 2050, this number will likely quadruple, meaning that 1 in 85 persons worldwide will be living with AD.1 This challenge is enormous and unquestionably critical to address. Imagine that if we can empower physicians to delay disease onset or progression by at least one year, there would be over nine million fewer cases of the disease in 2050!
By Roee Lazebnik, MD, PhD, Chief Medical Officer—
Magnetic Resonance Imaging, GE Healthcare
GE WORKS TO PROTECT